Search filters

Correction to Lancet Oncol 2015; 16: 499-508. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article
Author/s

author: Josep Tabernero Caturla 

Publication date May 27, 2015
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item